Established rheumatoid arthritis (RA) drug from AbbVie (adalimumab) shows promise in the treatment of uveitis
An international research collaboration between US and EU clinical investigators, led by Duke University, Durham, North Carolina, has shown that adalimumab, an anti-TNF-α antagonist, marketed… Read More »Established rheumatoid arthritis (RA) drug from AbbVie (adalimumab) shows promise in the treatment of uveitis